Department of Zoology, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda, 10250, Sri Lanka.
Department of Basic Science and Social Science for Nursing, Faculty of Nursing, University of Colombo, Sri Jayewardenepura, Thalapathpitiya, Nugegoda, 10250, Sri Lanka.
Mar Biotechnol (NY). 2024 Dec;26(6):1231-1245. doi: 10.1007/s10126-024-10368-y. Epub 2024 Sep 11.
The present study aimed to isolate a bioactive compound from Sri Lankan edible marine brown algae, Chnoospora minima, to manage diabetes. The de-polysaccharide crude methanolic extract was partitioned using hexane, chloroform, and ethyl acetate with increased polarity. The samples were subjected to determine the quantitative phytochemical analysis, antioxidants, and antidiabetic potentials. Further, the potent antidiabetic fraction was selected to isolate an active compound using bioactivity-guided fractionation. From the selected extract, the chloroform fraction exhibited comparatively high TPC (59.01 ± 1.86 mg GAE/g), TFC (5.14 ± 0.43 mg QE/g) and alkaloid content (2.79 ± 0.31 PE/g of extract). Crude methanol extract exhibited a potent DPPH activity (IC: 0.48 ± 0.01 mg/mL) whereas the ethyl acetate fraction elicited a maximum ABTS activity (IC: 0.064 ± 0.001 mg/mL) and a ferrous iron-chelating capacity (IC: 0.019 mg/mL). Similarly, the chloroform fraction exhibited the highest FRAP (20.34 ± 1.72 mg TE/g) and ORAC (19.72 ± 2.92 mg TE/g) capacities. The potent inhibitory activity of α-amylase (IC:3.17 ± 0.02 µg/mL) and α-glucosidase (IC: 1.99 ± 0.01 µg/mL) enzymes and glucose diffusion was observed in the chloroform fraction. Similarly, the chloroform extract exhibited a potent BSA-glucose (IC: 202.43 ± 5.71 µg/mL), BSA-MGO (IC: 124.30 ± 2.85 µg/mL) antiglycation model and reversing activities (EC: 98.99 ± 0.35 µg/mL; EC: 118.89 ± 1.58 µg/mL). Depending on the hypoglycemic activity, fucoxanthin was isolated as the active compound which showed a notable change in the functional group. Molecular docking studies were conducted on the compound, and binding energy was observed to be - 6.56 kcal/mol and - 4.83 kcal/mol for α-amylase and α-glucosidase enzymes, respectively, which confirmed the hypoglycemic effect of the isolated compounds. However, more studies are required to understand the mechanistic insights of these observations.
本研究旨在从斯里兰卡可食用海洋褐藻 Chnoospora minima 中分离出一种具有生物活性的化合物,以用于糖尿病的治疗。对去多糖粗甲醇提取物进行了正己烷、氯仿和乙酸乙酯的分步萃取,萃取溶剂的极性逐渐增加。对各萃取部位进行了定量的植物化学成分分析、抗氧化活性分析和抗糖尿病活性分析。然后,选择具有较强抗糖尿病活性的部位,通过生物活性导向的分步萃取法分离出活性化合物。在所选择的提取物中,氯仿部位表现出相对较高的总酚含量(59.01 ± 1.86 mg GAE/g)、总类黄酮含量(5.14 ± 0.43 mg QE/g)和生物碱含量(2.79 ± 0.31 PE/g 提取物)。粗甲醇提取物表现出较强的 DPPH 自由基清除活性(IC:0.48 ± 0.01 mg/mL),而乙酸乙酯部位则表现出最强的 ABTS 自由基清除活性(IC:0.064 ± 0.001 mg/mL)和亚铁离子螯合能力(IC:0.019 mg/mL)。同样,氯仿部位表现出最高的 FRAP(20.34 ± 1.72 mg TE/g)和 ORAC(19.72 ± 2.92 mg TE/g)能力。氯仿部位对α-淀粉酶(IC:3.17 ± 0.02 μg/mL)和α-葡萄糖苷酶(IC:1.99 ± 0.01 μg/mL)的抑制活性以及葡萄糖扩散均表现出较强的抑制作用。同样,氯仿提取物在 BSA-葡萄糖(IC:202.43 ± 5.71 μg/mL)、BSA-MGO(IC:124.30 ± 2.85 μg/mL)糖基化模型中表现出较强的抑制活性和还原能力(EC:98.99 ± 0.35 μg/mL;EC:118.89 ± 1.58 μg/mL)。根据降血糖活性,分离出了岩藻黄素作为活性化合物,其功能基团发生了明显变化。对化合物进行了分子对接研究,观察到其与α-淀粉酶和α-葡萄糖苷酶的结合能分别为-6.56 kcal/mol 和-4.83 kcal/mol,这证实了分离化合物的降血糖作用。然而,还需要更多的研究来深入了解这些观察结果的作用机制。